{"title":"经皮冠状动脉介入治疗延迟冠心病患者心律失常的起搏器植入。","authors":"Lihua Zhong, Yanhui Gao, Hongyuan Xia, Xueqi Li, Shipeng Wei","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pacemakers have long been used to assist the heart under pathological conditions, and they are the first choice in the treatment of systematic bradyarrhythmias. However, the effect of percutaneous coronary intervention (PCI) in patients with coronary artery disease as well as bradyarrhythmias remains unknown.</p><p><strong>Methods: </strong>In the present study, 42 patients with chest pain and/or abnormal stress test results were surveyed. Before coronary angiography, patients underwent complete examination, including a 24 h dynamic electrocardiogram, which was used to diagnose bradyarrhythmias that were not suitable for pacemaker implantation due to a lack of arrhythmia-related symptoms. All patients underwent PCI but did not undergo pacemaker implantation. Forty-one patients with chest pain and/or abnormal stress test results, as well as symptom-free bradyarrhythmias, were selected as the control group. All of the patients in the control group were committed to treatments without PCI.</p><p><strong>Results: </strong>During a mean (±SD) of 3.3±0.5 years of follow-up (range 2.5 to 4.5 years), 24 of 42 patients who received PCI underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and the remainder did not show any changes according to the examinations performed. In the control group, 31 patients underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and two did not show any changes according to the examinations performed. Nevertheless, the rates of pacemaker implantation each year (from the first to the third year) between the two groups were 7.1% versus 39.0% (P=0.001); 33.3% versus 63.4% (P=0.006); and 57.1% versus 75.6%, (P=0.075), respectively.</p><p><strong>Conclusions: </strong>The present study found that PCI delayed the demand for pacemaker implantation among coronary artery disease patients.</p>","PeriodicalId":54377,"journal":{"name":"Experimental & Clinical Cardiology","volume":"18 1","pages":"17-21"},"PeriodicalIF":0.0000,"publicationDate":"2013-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716496/pdf/ecc18e017.pdf","citationCount":"0","resultStr":"{\"title\":\"Percutaneous coronary intervention delays pacemaker implantation in coronary artery disease patients with established bradyarrhythmias.\",\"authors\":\"Lihua Zhong, Yanhui Gao, Hongyuan Xia, Xueqi Li, Shipeng Wei\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Pacemakers have long been used to assist the heart under pathological conditions, and they are the first choice in the treatment of systematic bradyarrhythmias. However, the effect of percutaneous coronary intervention (PCI) in patients with coronary artery disease as well as bradyarrhythmias remains unknown.</p><p><strong>Methods: </strong>In the present study, 42 patients with chest pain and/or abnormal stress test results were surveyed. Before coronary angiography, patients underwent complete examination, including a 24 h dynamic electrocardiogram, which was used to diagnose bradyarrhythmias that were not suitable for pacemaker implantation due to a lack of arrhythmia-related symptoms. All patients underwent PCI but did not undergo pacemaker implantation. Forty-one patients with chest pain and/or abnormal stress test results, as well as symptom-free bradyarrhythmias, were selected as the control group. All of the patients in the control group were committed to treatments without PCI.</p><p><strong>Results: </strong>During a mean (±SD) of 3.3±0.5 years of follow-up (range 2.5 to 4.5 years), 24 of 42 patients who received PCI underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and the remainder did not show any changes according to the examinations performed. In the control group, 31 patients underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and two did not show any changes according to the examinations performed. Nevertheless, the rates of pacemaker implantation each year (from the first to the third year) between the two groups were 7.1% versus 39.0% (P=0.001); 33.3% versus 63.4% (P=0.006); and 57.1% versus 75.6%, (P=0.075), respectively.</p><p><strong>Conclusions: </strong>The present study found that PCI delayed the demand for pacemaker implantation among coronary artery disease patients.</p>\",\"PeriodicalId\":54377,\"journal\":{\"name\":\"Experimental & Clinical Cardiology\",\"volume\":\"18 1\",\"pages\":\"17-21\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2013-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716496/pdf/ecc18e017.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Experimental & Clinical Cardiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Experimental & Clinical Cardiology","FirstCategoryId":"1085","ListUrlMain":"","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景:起搏器长期以来被用于病理状态下的心脏辅助,是治疗系统性慢性心律失常的首选。然而,经皮冠状动脉介入治疗(PCI)在冠状动脉疾病和慢速心律失常患者中的作用尚不清楚。方法:对42例胸痛和/或应激试验结果异常的患者进行调查。在冠状动脉造影前,患者接受了完整的检查,包括24小时动态心电图,用于诊断由于缺乏心律失常相关症状而不适合植入起搏器的慢速心律失常。所有患者均行PCI,但未行起搏器植入。选取胸痛和/或应激试验结果异常、无症状慢性心律失常患者41例作为对照组。对照组所有患者均承诺不进行PCI治疗。结果:在平均(±SD) 3.3±0.5年的随访期间(2.5 - 4.5年),42例接受PCI治疗的患者中有24例因心律失常相关症状接受了起搏器植入,其中8例通过霍尔特监测显示病情恶化但仍无症状,其余患者根据检查未显示任何变化。在对照组中,31例患者因心律失常相关症状接受了起搏器植入,其中8例通过霍尔特监测显示病情恶化但仍无症状,2例检查未显示任何变化。然而,两组每年(从第一年到第三年)起搏器植入率分别为7.1%和39.0% (P=0.001);33.3%对63.4% (P=0.006);57.1% vs 75.6% (P=0.075)。结论:本研究发现PCI延迟了冠状动脉疾病患者对起搏器植入的需求。
Percutaneous coronary intervention delays pacemaker implantation in coronary artery disease patients with established bradyarrhythmias.
Background: Pacemakers have long been used to assist the heart under pathological conditions, and they are the first choice in the treatment of systematic bradyarrhythmias. However, the effect of percutaneous coronary intervention (PCI) in patients with coronary artery disease as well as bradyarrhythmias remains unknown.
Methods: In the present study, 42 patients with chest pain and/or abnormal stress test results were surveyed. Before coronary angiography, patients underwent complete examination, including a 24 h dynamic electrocardiogram, which was used to diagnose bradyarrhythmias that were not suitable for pacemaker implantation due to a lack of arrhythmia-related symptoms. All patients underwent PCI but did not undergo pacemaker implantation. Forty-one patients with chest pain and/or abnormal stress test results, as well as symptom-free bradyarrhythmias, were selected as the control group. All of the patients in the control group were committed to treatments without PCI.
Results: During a mean (±SD) of 3.3±0.5 years of follow-up (range 2.5 to 4.5 years), 24 of 42 patients who received PCI underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and the remainder did not show any changes according to the examinations performed. In the control group, 31 patients underwent pacemaker implantation for arrhythmia-related symptoms, eight were shown by Holter monitoring to have worsened but still exhibited no symptoms, and two did not show any changes according to the examinations performed. Nevertheless, the rates of pacemaker implantation each year (from the first to the third year) between the two groups were 7.1% versus 39.0% (P=0.001); 33.3% versus 63.4% (P=0.006); and 57.1% versus 75.6%, (P=0.075), respectively.
Conclusions: The present study found that PCI delayed the demand for pacemaker implantation among coronary artery disease patients.